Add to Calendar 07/26/2017 11:30 07/26/2017 13:00 America/Los_Angeles Los Angeles Medical Device Lunch-n-Learn Combination Products: Is It a Drug, or Is It a Device?<br>As more companies develop combination products, it is critical to understand the regulatory interface between biopharmaceuticals and medical devices/diagnostics when planning for product development and market entry.  Strategic plans can be greatly impacted by the lack of clarity regarding the primary mode of action.  Minnie Baylor-Henry will share insights as to how best to navigate the regulatory landscape of these combination products and prepare for a pathway to success.<br><br><br><br>  Biocom halhakim@biocom.org false MM/DD/YYYY